Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Marc-Henri Galletti
AddedMar 31, 2024
UpdatedMay 31, 2026
Marc-Henri Galletti

Marc-Henri Galletti

Co-Founder, Longitude Capital

CrunchbaseLinkedIn

Marc-Henri Galletti's Career

Longitude Capital
Longitude Capital

Menlo Park, CA, US

Co-Founder
Velomedix
Velomedix

Menlo Park, CA, US

Board Member· Board
Murj
Murj

Santa Cruz, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Marc-Henri Galletti's Career

Longitude Capital
Longitude Capital
Investment FirmInvestment Firm452006Menlo Park, CA, US
Co-Founder

Leadership at Longitude Capital

Andrew CleelandAndrew CleelandBoard Member
David HirschDavid HirschCo-Founder
Lisa SuennenLisa SuennenBoard Member
Patrick EnrightPatrick EnrightCo-Founder
Andrew ElbardissiAndrew ElbardissiBoard Member
Juliet Tammenoms BakkerJuliet Tammenoms BakkerCo-Founder

Similar to Longitude Capital

Longwood FundLongwood FundBoston, MA, USest. 2010Longwood FundBoston, MA, US · est. 2010

Longwood Fund Management: A US-based venture capital firm specializing in healthcare and biotech investments.

Investment Firm20
Longevity Vision FundLongevity Vision FundNew York City, NY, USest. 2019Longevity Vision FundNew York City, NY, US · est. 2019

LVF: A venture capital fund investing in disruptive healthcare technologies for longer, healthier lives.

Investment Firm15
Longley CapitalLongley CapitalSan Diego, CA, USest. 2019Longley CapitalSan Diego, CA, US · est. 2019

Longley Capital: A tech-focused investment firm, nurturing visionary ideas to boost enterprise value.

Investment Firm2
The Longevity FundThe Longevity FundSan Francisco, CA, USest. 2011The Longevity FundSan Francisco, CA, US · est. 2011

Longevity Fund: Investing in human longevity through innovative investment solutions.

Investment Firm2
Velomedix
Velomedix
Series C$19M302007Menlo Park, CA, US
Board Member· Board

Leadership at Velomedix

Jeffrey GoldJeffrey GoldCEO

Similar to Velomedix

Velico MedicalVelico MedicalBeverly, MA, USMedical Technologyest. 1991Velico MedicalBeverly, MA, US · est. 1991

Pre-clinical med-tech firm enhancing plasma & platelet transfusion availability and economics.

Series B · $19M28
Velosal MedicalVelosal MedicalCary, NC, USMedical Devicesest. 2014Velosal MedicalCary, NC, US · est. 2014

Velosal Medical: A Delaware-based innovator in critical care and emergency medical devices since 2014.

Angel · $250k5
NeuroSaveNeuroSaveSan Francisco, CA, USMedical Devicesest. 2010NeuroSaveSan Francisco, CA, US · est. 2010

NeuroSave: A clinical-stage medical device company specializing in rapid, targeted brain cooling to prevent ischemic injury.

Pre-Seed · $1.3M30
BiomedInnovationsBiomedInnovationsDenver, NC, USMedical Devicesest. 2015BiomedInnovationsDenver, NC, US · est. 2015

BiomedInnovations: Pioneering tech for long-term storage and interaction with human tissues/organs.

Angel · $250k12
Murj
Murj
Series B$14.1M1062014Santa Cruz, CA, US
Board Member· Board

Leadership at Murj

Chris IrvingChris IrvingCo-Founder
Todd ButkaTodd ButkaCo-Founder
Jon CallaghanJon CallaghanBoard Member

Similar to Murj

HeartCloudHeartCloudLos Angeles, CA, USRemote Patient Monitoringest. 2018HeartCloudLos Angeles, CA, US · est. 2018

HeartCloud: A secure web app enhancing smartwatch functionality for comprehensive health tracking.

Seed · $1.7M16
InvisionHeartInvisionHeartNashville, TN, USMedical Devicesest. 2013InvisionHeartNashville, TN, US · est. 2013

InvisionHeart: Experienced leadership in robust software and hardware development.

Series A · $1.9M30
CommureCommureSan Francisco, CA, USHealthcare Softwareest. 2017CommureSan Francisco, CA, US · est. 2017

Commure, Inc.: Innovating healthcare with software solutions for seamless, secure, and efficient care delivery.

Series D · $616M248

Marc-Henri Galletti's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Marc-Henri Galletti

Marco MarinucciMarco MarinucciBoard Member · AEyeNeil RatnaNeil RatnaCo-Founder · TunnelFlip GianosFlip GianosBoard Member · Pelican ImagingChris MeyerChris MeyerBoard Member · Born CapitalSam MarleySam MarleyCo-Founder · BlurrBrian ReillyBrian ReillyCo-Founder · Will Ventures